iTeos Therapeutics, Inc. (ITOS) Misses Q4 EPS by 2c

iTeos Therapeutics, Inc. (NASDAQ: ITOS) reported Q4 EPS of ($0.85), $0.02 worse than the analyst estimate of ($0.83).

For earnings history and earnings-related data on iTeos Therapeutics, Inc. (ITOS) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c